1. Home
  2. XOMA vs VACH Comparison

XOMA vs VACH Comparison

Compare XOMA & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • VACH
  • Stock Information
  • Founded
  • XOMA 1981
  • VACH 2023
  • Country
  • XOMA United States
  • VACH United States
  • Employees
  • XOMA N/A
  • VACH N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • VACH
  • Sector
  • XOMA Health Care
  • VACH
  • Exchange
  • XOMA Nasdaq
  • VACH NYSE
  • Market Cap
  • XOMA 300.5M
  • VACH 324.2M
  • IPO Year
  • XOMA N/A
  • VACH 2024
  • Fundamental
  • Price
  • XOMA $24.22
  • VACH $10.33
  • Analyst Decision
  • XOMA Strong Buy
  • VACH
  • Analyst Count
  • XOMA 2
  • VACH 0
  • Target Price
  • XOMA $69.50
  • VACH N/A
  • AVG Volume (30 Days)
  • XOMA 46.8K
  • VACH 32.4K
  • Earning Date
  • XOMA 05-13-2025
  • VACH 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • VACH N/A
  • EPS Growth
  • XOMA N/A
  • VACH N/A
  • EPS
  • XOMA N/A
  • VACH 0.30
  • Revenue
  • XOMA $42,909,000.00
  • VACH N/A
  • Revenue This Year
  • XOMA $24.96
  • VACH N/A
  • Revenue Next Year
  • XOMA $26.75
  • VACH N/A
  • P/E Ratio
  • XOMA N/A
  • VACH $34.37
  • Revenue Growth
  • XOMA 638.41
  • VACH N/A
  • 52 Week Low
  • XOMA $18.35
  • VACH $9.95
  • 52 Week High
  • XOMA $35.00
  • VACH $11.20
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 46.84
  • VACH N/A
  • Support Level
  • XOMA $24.50
  • VACH N/A
  • Resistance Level
  • XOMA $27.00
  • VACH N/A
  • Average True Range (ATR)
  • XOMA 1.41
  • VACH 0.00
  • MACD
  • XOMA -0.32
  • VACH 0.00
  • Stochastic Oscillator
  • XOMA 4.93
  • VACH 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About VACH VOYAGER ACQUISITION CORP.

Voyager Acquisition Corp is a blank check company.

Share on Social Networks: